Skip to main content
SpringerLink
Log in

Angiogenesis in Gliomas

  • Chapter
Gliomas

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 171))

Angiogenesis, the sprouting of new blood vessels from preexisting blood vessels, is a hallmark of glioma progression. Malignant gliomas are among the most lethal tumors with a very dismal prognosis, despite advances in standard therapy, including surgery, radiation, and chemotherapy. The median survival of patients with malignant gliomas has changed little in the last few years and is still measured in months. In an attempt to develop new therapeutic strategies and identify the molecular mechanism involved in glioma growth and progression, there has been extraordinary scientific interest in the past 2 decades in angiogenic responses associated with gliomas. This chapter focuses on the molecular mechanism of glioma angiogenesis and summarizes some of the therapeutic approaches based on antiangiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Acker T, Diez-Juan A, Aragones J, Tjwa M, Brusselmans K, Moons L, Fukumura D, Moreno-Murciano MP, Herbert JM, Burger A, Riedel J, Elvert G, Flamme I, Maxwell PH, Collen D, Dewerchin M, Jain RK, Plate KH, Carmeliet P (2005) Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell. 8:131–141

    PubMed  CAS  Google Scholar 

  • Adini A, Kornaga T, Firoozbakht F, Benjamin LE (2002) Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62 2749–2752

    PubMed  CAS  Google Scholar 

  • Albini A, Noonan D, Santi L (1999) Angiogenesis at the interface between basic and clinical research. Int J Biol Markers 14:202–206

    PubMed  CAS  Google Scholar 

  • Arrieta O, Guevara P, Tamariz J, Rembao D, Rivera E, Sotelo J (2002) Antiproliferative effect of thalido-mide alone and combined with carmustine against C6 rat glioma. Int J Exp Pathol 83:99–104

    PubMed  CAS  Google Scholar 

  • Audero E, Cascone I, Zanon I, Previtali SC, Piva R, Schiffer D, Bussolino F (2001) Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies. Arterioscler Thromb Vasc Biol 21:536–541

    PubMed  CAS  Google Scholar 

  • Augustin HG, Reiss Y (2003) EphB receptors and ephrinB ligands: regulators of vascular assembly and homeostasis. Cell Tissue Res 314:25–31

    PubMed  CAS  Google Scholar 

  • Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843–7848

    PubMed  CAS  Google Scholar 

  • Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83–95

    PubMed  CAS  Google Scholar 

  • Baumann F, Bjeljac M, Kollias SS, Baumert BG, Brandner S, Rousson V, Yonekawa Y, Bernays RL (2004) Combined thalidomide and temozolo-mide treatment in patients with glioblastoma multiforme. J Neurooncol 67:191–200

    PubMed  Google Scholar 

  • Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS, Nikas DC, Strasser JF, Villani R, Cheresh DA, Black PM (2001) Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49:380–389

    PubMed  CAS  Google Scholar 

  • Benedito R, Duarte A (2005) Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles. Gene Expr Patterns 5:750–755

    PubMed  CAS  Google Scholar 

  • Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L, Adini I, Pravda E, Nahmias Y, Koirala S, Corfas G, D'Amato RJ, Folkman J (2008) An orally delivered small-molecule formulation with antiang-iogenic and anticancer activity. Nat Biotechnol 26(7):799–807

    PubMed  CAS  Google Scholar 

  • Bian XW, Du LL, Shi JQ, Cheng YS, Liu FX (2000) Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal Quant Cytol Histol 22:267–274

    PubMed  CAS  Google Scholar 

  • Board R, Jayson GC (2005) Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics. Drug Resist Updat 8:75–83

    PubMed  CAS  Google Scholar 

  • Brat DJ, Bellail AC, Van Meir EG (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neurooncol 7:122–133

    CAS  Google Scholar 

  • Breier G, Blum S, Peli J, Groot M, Wild C, Risau W, Reichmann E (2002) Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis. Int J Cancer 97:142–148

    PubMed  CAS  Google Scholar 

  • Broholm H, Laursen H (2004) Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. APMIS 112:257–263

    PubMed  CAS  Google Scholar 

  • Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92:391–400

    PubMed  CAS  Google Scholar 

  • Burger PC, Fuller GN (1991) Pathology–trends and pitfalls in histologic diagnosis, immunopathology, and applications of oncogene research. Neurol Clin 9:249–271

    PubMed  CAS  Google Scholar 

  • Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257

    PubMed  CAS  Google Scholar 

  • Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575–583

    PubMed  CAS  Google Scholar 

  • Carmeliet P, Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436:193–200

    PubMed  CAS  Google Scholar 

  • Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD (2004) Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 60:353–357

    PubMed  CAS  Google Scholar 

  • Cheng N, Brantley DM, Chen J (2002) The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13:75–85

    PubMed  CAS  Google Scholar 

  • Cirulli V, Yebra M (2007) Netrins: beyond the brain. Nat Rev Mol Cell Biol 8:296–306

    PubMed  CAS  Google Scholar 

  • Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629–17634

    PubMed  CAS  Google Scholar 

  • Cohen MH (2000) Thalidomide in the treatment of high-grade gliomas. J Clin Oncol 18:3453

    PubMed  CAS  Google Scholar 

  • Correa RG, Sasahara RM, Bengtson MH, Katayama ML, Salim AC, Brentani MM, Sogayar MC, de Souza SJ, Simpson AJ (2001) Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines. Genomics 73:343–348

    PubMed  CAS  Google Scholar 

  • D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082–4085

    PubMed  Google Scholar 

  • Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15:1913–1925

    PubMed  CAS  Google Scholar 

  • Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F (2003) Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 22:4611–4616

    PubMed  CAS  Google Scholar 

  • Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxiadriven mechanisms. Cancer Res 57:3860–3864

    PubMed  CAS  Google Scholar 

  • Desbaillets I, Diserens AC, de Tribolet N, Hamou MF, Van Meir EG (1999) Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18:1447–1456

    PubMed  CAS  Google Scholar 

  • Drevs J, Laus C, Medinger M, Schmidt-Gersbach C, Unger C (2002) Antiangiogenesis: current clinical data and future perspectives. Onkologie 25:520–527

    PubMed  CAS  Google Scholar 

  • Duda DG (2006) Antiangiogenesis and drug delivery to tumors: bench to bedside and back. Cancer Res 66:3967–3970

    PubMed  CAS  Google Scholar 

  • Dunn IF, Heese O, Black PM (2000) Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol 50:121–137

    PubMed  CAS  Google Scholar 

  • Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P (2006) EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25:628–641

    PubMed  CAS  Google Scholar 

  • Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56

    PubMed  CAS  Google Scholar 

  • Fenton BM, Paoni SF, Ding I (2004) Effect of VEGF receptor-2 antibody on vascular function and oxygenation in spontaneous and transplanted tumors. Radiother Oncol 72:221–230

    PubMed  CAS  Google Scholar 

  • Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676

    PubMed  CAS  Google Scholar 

  • Fiedler U, Augustin HG (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 27:552–558

    PubMed  CAS  Google Scholar 

  • Fine HA, Figg WD, Jaeckle K, Wen PY, Kyritsis AP, Loeffler JS, Levin VA, Black PM, Kaplan R, Pluda JM, Yung WK (2000) Phase II trial of the antiang-iogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol 18:708–715

    PubMed  CAS  Google Scholar 

  • Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB (2003) Phase II trial of thalidomide and carmus-tine for patients with recurrent high-grade gliomas. J Clin Oncol 21:2299–2304

    PubMed  CAS  Google Scholar 

  • Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, Autiero M, Wyns S, Plaisance S, Moons L, van Rooijen N, Giacca M, Stassen JM, Dewerchin M, Collen D, Carmeliet P (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131:463–475

    PubMed  CAS  Google Scholar 

  • Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43:175–203

    PubMed  CAS  Google Scholar 

  • Folkman J (1996) Endogenous inhibitors of angiogenesis. Harvey Lect. 92:65–82

    PubMed  Google Scholar 

  • Forcet C, Stein E, Pays L, Corset V, Llambi F, Tessier-Lavigne M, Mehlen P (2002) Netrin-1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation. Nature 417:443–447

    PubMed  CAS  Google Scholar 

  • Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, Thurston G, Yancopoulos GD (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101:15949–15954

    PubMed  CAS  Google Scholar 

  • Goldbrunner RH, Bendszus M, Wood J, Kiderlen M, Sasaki M, Tonn JC (2004) PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization. Neurosurgery 55:426–432

    PubMed  Google Scholar 

  • Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA, Yung WK (2003) Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol 53:109–117

    PubMed  CAS  Google Scholar 

  • Grau SJ, Trillsch F, Herms J, Thon N, Nelson PJ, Tonn JC, Goldbrunner R (2007) Expression of VEGFR3 in glioma endothelium correlates with tumor grade. J Neurooncol 82:141–150

    PubMed  CAS  Google Scholar 

  • Gridley T (2007) Notch signaling in vascular development and physiology. Development 134:2709–2718

    PubMed  CAS  Google Scholar 

  • Groves MD, Puduvalli VK, Conrad CA, Gilbert MR, Yung WK, Jaeckle K, Liu V, Hess KR, Aldape KD, Levin VA (2006) Phase II trial of temozolo-mide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status. J Neurooncol 80:83–90

    PubMed  CAS  Google Scholar 

  • Guan M, Pang CP, Yam HF, Cheung KF, Liu WW, Lu Y (2004) Inhibition of glioma invasion by overex-pression of pigment epithelium-derived factor. Cancer Gene Ther 11:325–332

    PubMed  CAS  Google Scholar 

  • Heidenreich R, Machein M, Nicolaus A, Hilbig A, Wild C, Clauss M, Plate KH, Breier G (2004) Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants. Int J Cancer 111:348–357

    PubMed  CAS  Google Scholar 

  • Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994–1998

    PubMed  CAS  Google Scholar 

  • Hong K, Hinck L, Nishiyama M, Poo MM, Tessier-Lavigne M, Stein E (1999) A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 97:927–941

    PubMed  CAS  Google Scholar 

  • Hu B, Guo P, Fang Q, Tao HQ, Wang D, Nagane M, Huang HJ, Gunji Y, Nishikawa R, Alitalo K, Cavenee WK, Cheng SY (2003) Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci USA 100:8904–8909

    PubMed  CAS  Google Scholar 

  • Izumi Y, di Tomaso E, Hooper A, Huang P, Huber J, Hicklin DJ, Fukumura D, Jain RK, Suit HD (2003) Responses to antiangiogenesis treatment of spontaneous autochthonous tumors and their isografts. Cancer Res 63:747–751

    PubMed  CAS  Google Scholar 

  • Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58–62

    PubMed  CAS  Google Scholar 

  • Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610–622

    PubMed  CAS  Google Scholar 

  • Jain RK, Duda DG, Clark JW, Loeffler JS (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3:24–40

    PubMed  CAS  Google Scholar 

  • Janson, ET, Oberg K (2002) Malignant neuroendocrine tumors. Cancer Chemother. Biol Response Modif 20:463–470

    PubMed  Google Scholar 

  • Jeffers M, Rong S, Woude GF (1996) Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74:505–513

    PubMed  CAS  Google Scholar 

  • Jenny B, Harrison JA, Baetens D, Tille JC, Burkhardt K, Mottaz H, Kiss JZ, Dietrich PY, de Tribolet N, Pizzolato GP, Pepper MS (2006) Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas. J Pathol 209:34–43

    PubMed  CAS  Google Scholar 

  • Jouanneau E (2008) Angiogenesis and gliomas: current issues and development of surrogate markers. Neurosurgery 62:31–50

    PubMed  Google Scholar 

  • Kabrun N, Buhring HJ, Choi K, Ullrich A, Risau W, Keller G (1997) Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:2039–2048

    PubMed  CAS  Google Scholar 

  • Kaminska B, Wesolowska A, Danilkiewicz M (2005) TGF beta signalling and its role in tumour pathogenesis. Acta Biochim Pol 52:329–337

    PubMed  CAS  Google Scholar 

  • Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neurooncol 7:134–153

    CAS  Google Scholar 

  • Kazuno M, Tokunaga T, Oshika Y, Tanaka Y, Tsugane R, Kijima H, Yamazaki H, Ueyama Y, Nakamura M (1999) Thrombospondin-2 (TSP2) expression is inversely correlated with vascularity in glioma. Eur J Cancer 35:502–506

    PubMed  CAS  Google Scholar 

  • Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039–2049

    PubMed  CAS  Google Scholar 

  • Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski, V, Waltenberger J, Shibuya M, Plate KH, Machein MR (2008) Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res 68(18):7342–7351

    PubMed  CAS  Google Scholar 

  • Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angio-genesis suppresses tumour growth in vivo. Nature 362:841–844

    PubMed  CAS  Google Scholar 

  • Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al Hashem R, Kim SU, Black PM, Carroll RS (2005) PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 11:5965–5970

    PubMed  CAS  Google Scholar 

  • Kirsch M, Schackert G, Black PM (2000) Angiogenesis, metastasis, and endogenous inhibition. J Neurooncol 50:173–180

    PubMed  CAS  Google Scholar 

  • Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM (1998) Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 58:4654–4659

    PubMed  CAS  Google Scholar 

  • Klein R (2001) Excitatory Eph receptors and adhesive ephrin ligands. Curr Opin Cell Biol 13:196–203

    PubMed  CAS  Google Scholar 

  • Kragh M, Spang-Thomsen M, Kristjansen PE (1999) Time until initiation of tumor growth is an effective measure of the anti-angiogenic effect of TNP-470 on human glioblastoma in nude mice. Oncol Rep 6:759–762

    PubMed  CAS  Google Scholar 

  • Kruger RP, Aurandt J, Guan KL (2005) Semaphorins command cells to move. Nat Rev Mol Cell Biol 6:789–800

    PubMed  CAS  Google Scholar 

  • Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Williams NN, Kaiser LR, Croce CM (2003) Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res 63:3352–3355

    PubMed  CAS  Google Scholar 

  • Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS (2004) Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23:4681–4689

    PubMed  CAS  Google Scholar 

  • Lamszus K, Laterra J, Westphal M, Rosen EM (1999) Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 17:517–530

    PubMed  CAS  Google Scholar 

  • Lamszus K, Ulbricht U, Matschke J, Brockmann MA, Fillbrandt R, Westphal M (2003) Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A. Clin Cancer Res 9:1399–1405

    PubMed  CAS  Google Scholar 

  • Larrivee B, Freitas C, Trombe M, Lv X, Delafarge B, Yuan L, Bouvree K, Breant C, Del Toro R, Brechot N, Germain S, Bono F, Dol F, Claes F, Fischer C, Autiero M, Thomas JL, Carmeliet P, Tessier-Lavigne M, Eichmann A (2007) Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev 21:2433–2447

    PubMed  CAS  Google Scholar 

  • Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y (2000) Anti-vascular endothelial growth factor treatment augments tumor radiation response under nor-moxic or hypoxic conditions. Cancer Res 60:5565–5570

    PubMed  CAS  Google Scholar 

  • Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL (2007) Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67:11244–11253

    PubMed  CAS  Google Scholar 

  • Lund EL, Bastholm L, Kristjansen PE (2000) Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblast-oma multiforme xenografts. Clin Cancer Res 6:971–978

    PubMed  CAS  Google Scholar 

  • Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM (2001) Pharmacodynamic-mediated reduction of temo-zolomide tumor concentrations by the angio-genesis inhibitor TNP-470. Cancer Res 61:5491–5498

    PubMed  CAS  Google Scholar 

  • Machein MR, Knedla A, Knoth R, Wagner S, Neuschl E, Plate KH (2004) Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am J Pathol 165:1557–1570

    PubMed  CAS  Google Scholar 

  • Machein MR, Plate KH (2000) VEGF in brain tumors. J Neurooncol 50:109–120

    PubMed  CAS  Google Scholar 

  • Machein MR, Risau W, Plate KH (1999) Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2. Hum Gene Ther 10:1117–1128

    PubMed  CAS  Google Scholar 

  • Maity A, Pore N, Lee J, Solomon D, O'Rourke DM (2000) Epidermal growth factor receptor tran-scriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinosi-tol 3 -kinase and distinct from that induced by hypoxia. Cancer Res 60:5879–5886

    PubMed  CAS  Google Scholar 

  • McDonald DM, Teicher BA, Stetler-Stevenson W, Ng SS, Figg WD, Folkman J, Hanahan D, Auerbach R, O'Reilly M, Herbst R, Cheresh D, Gordon M, Eggermont A, Libutti SK (2004) Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoring. J Immunother 27:161–175

    PubMed  Google Scholar 

  • Mertsch S, Schmitz N, Jeibmann A, Geng JG, Paulus W, Senner V (2008) Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol 87:1–7

    PubMed  CAS  Google Scholar 

  • Meyerhardt JA, Caca K, Eckstrand BC, Hu G, Lengauer C, Banavali S, Look AT, Fearon ER (1999) Netrin-1: interaction with deleted in color-ectal cancer (DCC) and alterations in brain tumors and neuroblastomas. Cell Growth Differ 10:35–42

    PubMed  CAS  Google Scholar 

  • Mignatti P, Morimoto T, Rifkin DB (1991) Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an auto-crine manner. Proc Natl Acad Sci USA 88:11007–11011

    PubMed  CAS  Google Scholar 

  • Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576–579

    PubMed  CAS  Google Scholar 

  • Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculo-genesis and angiogenesis. Cell 72:835–846

    PubMed  CAS  Google Scholar 

  • Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, Yano T, Shibata M, Ohno K, Hirakawa K, Yamaguchi N (2002) Increased levels of tissue endostatin in human malignant gliomas. Clin Cancer Res 8:2933–2938

    PubMed  CAS  Google Scholar 

  • Murata R, Nishimura Y, Hiraoka M (1997) An antiangiogenic agent (TNP-470) inhibited reoxy-genation during fractionated radiotherapy of murine mammary carcinoma. Int J Radiat Oncol Biol Phys 37:1107–1113

    PubMed  CAS  Google Scholar 

  • Nakada M, Drake KL, Nakada S, Niska JA, Berens ME (2006) Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Res 66:8492–8500

    PubMed  CAS  Google Scholar 

  • Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME (2005) EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol 167:565–576

    PubMed  CAS  Google Scholar 

  • Neufeld G, Kessler O (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 8:632–645

    PubMed  CAS  Google Scholar 

  • Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444:1032–1037

    PubMed  CAS  Google Scholar 

  • Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G (2007) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Novartis Found Symp 283:106–120

    PubMed  CAS  Google Scholar 

  • Nomura M, Yamagishi S, Harada S, Yamashima T, Yamashita J, Yamamoto H (1998) Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 40:123–130

    PubMed  CAS  Google Scholar 

  • Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65:3967–3979

    PubMed  CAS  Google Scholar 

  • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285

    PubMed  Google Scholar 

  • O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y, Moses M, Lane WS, Sage EH, Folkman J (1994) Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 59:471–482

    PubMed  Google Scholar 

  • Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359–371

    PubMed  CAS  Google Scholar 

  • Osada H, Tokunaga T, Nishi M, Hatanaka H, Abe Y, Tsugu A, Kijima H, Yamazaki H, Ueyama Y, Nakamura M (2004) Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res 24:547–552

    PubMed  CAS  Google Scholar 

  • Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822–5827

    PubMed  CAS  Google Scholar 

  • Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520–529

    PubMed  CAS  Google Scholar 

  • Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848

    PubMed  CAS  Google Scholar 

  • Platten M, Wick W, Weller M (2001) Malignant glioma biology: role for TGF-beta in growth, motil-ity, angiogenesis, and immune escape. Microsc Res Tech 52:401–410

    PubMed  CAS  Google Scholar 

  • Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65:2353–2363

    PubMed  CAS  Google Scholar 

  • Read TA, Sorensen DR, Mahesparan R, Enger PO, Timpl R, Olsen BR, Hjelstuen MH, Haraldseth O, Bjerkvig R (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol 19:29–34

    PubMed  CAS  Google Scholar 

  • Rege TA, Fears CY, Gladson CL (2005) Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy. Neurooncol 7:106–121

    CAS  Google Scholar 

  • Reiss Y, Machein MR, Plate KH (2005) The role of angiopoietins during angiogenesis in gliomas. Brain Pathol 15:311–317

    PubMed  CAS  Google Scholar 

  • Rieger J, Wick W, Weller M (2003) Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42:379–389

    PubMed  Google Scholar 

  • Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin CH (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7:261–266

    PubMed  CAS  Google Scholar 

  • Rodrigues S, De Wever O, Bruyneel E, Rooney RJ, Gespach C (2007) Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Oncogene 26:5615–5625

    PubMed  CAS  Google Scholar 

  • Rolny C, Capparuccia L, Casazza A, Mazzone M, Vallario A, Cignetti A, Medico E, Carmeliet P, Comoglio PM, Tamagnone L (2008) The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J Exp Med 205:1155–1171

    PubMed  CAS  Google Scholar 

  • Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) ‘Pseudopalisading’ necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65:529–539

    PubMed  Google Scholar 

  • Rong Y, Post DE, Pieper RO, Durden DL, Van Meir EG, Brat DJ (2005) PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 65:1406–1413

    PubMed  CAS  Google Scholar 

  • Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA (2000) Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2:306–314

    PubMed  CAS  Google Scholar 

  • Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189–1193

    PubMed  CAS  Google Scholar 

  • Sasaki M, Wizigmann-Voos S, Risau W, Plate KH (1999) Retrovirus producer cells encoding anti-sense VEGF prolong survival of rats with intrac-ranial GS9L gliomas. Int J Dev Neurosci 17:579–591

    PubMed  CAS  Google Scholar 

  • Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metallo-proteinase expressed on the surface of invasive tumour cells. Nature 370:61–65

    PubMed  CAS  Google Scholar 

  • Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70–74

    PubMed  CAS  Google Scholar 

  • Schmidt NO, Westphal M, Hagel C, Ergun S, Stavrou D, Rosen EM, Lamszus K (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84:10–18

    PubMed  CAS  Google Scholar 

  • Schnurch H, Risau W (1993) Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119:957–968

    PubMed  CAS  Google Scholar 

  • Schueneman AJ, Himmelfarb E, Geng L, Tan J, Donnelly E, Mendel D, McMahon G, Hallahan DE (2003) SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res 63:4009–4016

    PubMed  CAS  Google Scholar 

  • Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447–5454

    PubMed  CAS  Google Scholar 

  • Shekarabi M, Kennedy TE (2002) The netrin-1 receptor DCC promotes filopodia formation and cell spreading by activating Cdc42 and Rac1. Mol Cell Neurosci 19:1–17

    PubMed  CAS  Google Scholar 

  • Shibuya M (2006) Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 9:225–230

    PubMed  CAS  Google Scholar 

  • Shih AH, Holland EC (2006a) Notch signaling enhances nestin expression in gliomas. Neoplasia 8:1072–1082

    CAS  Google Scholar 

  • Shih AH, Holland EC (2006b) Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 232:139–147

    CAS  Google Scholar 

  • Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845

    PubMed  CAS  Google Scholar 

  • Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropi-lin-1 that enhance VEGF165-receptor binding. J Cell Biochem 85:357–368

    PubMed  CAS  Google Scholar 

  • Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 20;92:735–745

    CAS  Google Scholar 

  • Stratmann A, Machein MR, Plate KH (1997) Anti-angiogenic gene therapy of malignant glioma. Acta Neurochir (Suppl. 68):105–110

    Google Scholar 

  • Stratmann A, Risau W, Plate KH (1998) Cell type-specific expression of angiopoietin-1 and angi-opoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153:1459–1466

    PubMed  CAS  Google Scholar 

  • Strik HM, Schluesener HJ, Seid K, Meyermann R, Deininger MH (2001) Localization of endostatin in rat and human gliomas. Cancer 91:1013–1019

    PubMed  CAS  Google Scholar 

  • Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, Kuo IH, Chen HY, Hung MC, Kuo ML (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96:541–545

    PubMed  CAS  Google Scholar 

  • Taga T, Suzuki A, Gonzalez-Gomez I, Gilles FH, Stins M, Shimada H, Barsky L, Weinberg KI, Laug WE (2002) Alpha v-integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin. Int J Cancer 98:690–697

    PubMed  CAS  Google Scholar 

  • Takamiya Y, Brem H, Ojeifo J, Mineta T, Martuza RL (1994) AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery 34:869–875

    PubMed  CAS  Google Scholar 

  • Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, Waltari M, Hellstrom M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Yla-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454:656–660

    PubMed  CAS  Google Scholar 

  • Tenan M, Fulci G, Albertoni M, Diserens AC, Hamou MF, Atifi-Borel M, Feige JJ, Pepper MS, Van Meir EG (2000) Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. J Exp Med 191:1789–1798

    PubMed  CAS  Google Scholar 

  • Thorns V, Walter GF, Thorns C (2003) Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23:3937–3944

    PubMed  CAS  Google Scholar 

  • Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF, Minna JD (2001) Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 98:13954–13959

    PubMed  CAS  Google Scholar 

  • Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, Wagner S, Vince GH, Roosen K (1999) Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 80:764–772

    PubMed  CAS  Google Scholar 

  • Tsai JC, Goldman CK, Gillespie GY (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82:864–873

    PubMed  CAS  Google Scholar 

  • Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381–1390

    PubMed  CAS  Google Scholar 

  • Van Meir EG, Polverini PJ, Chazin VR, Su Huang HJ, de Tribolet N, Cavenee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 8:171–176

    Google Scholar 

  • Vitolo D, Paradiso P, Uccini S, Ruco LP, Baroni CD (1996) Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread. Histopathology 28:521–528

    PubMed  CAS  Google Scholar 

  • Vredenburgh JJ, Desjardins A, Herndon JE, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS (2007a) Phase II trial of bevaci-zumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13:1253–1259

    CAS  Google Scholar 

  • Vredenburgh JJ, Desjardins A, Herndon JE, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007b) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 20;25:4722–4729

    CAS  Google Scholar 

  • Wang B, Xiao Y, Ding BB, Zhang N, Yuan X, Gui L, Qian KX, Duan S, Chen Z, Rao Y, Geng JG (2003) Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 4:19–29

    PubMed  Google Scholar 

  • Weindel K, Moringlane JR, Marme D, Weich HA (1994) Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35: 439–448

    PubMed  CAS  Google Scholar 

  • Werbowetski-Ogilvie TE, Seyed SM, Jabado N, Angers-Loustau A, Agar NY, Wu J, Bjerkvig R, Antel JP, Faury D, Rao Y, Del Maestro RF (2006) Inhibition of medulloblastoma cell invasion by Slit. Oncogene 25:5103–5112

    PubMed  CAS  Google Scholar 

  • Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53: 177–185

    PubMed  CAS  Google Scholar 

  • Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, Schlingemann RO (2001) VEGFR-3 in adult angiogenesis. J Pathol 195:490–497

    PubMed  CAS  Google Scholar 

  • Wong K, Park HT, Wu JY, Rao Y (2002) Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. Curr Opin Genet Dev 12:583–591

    PubMed  CAS  Google Scholar 

  • Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin CH, Funa K (1995) Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int J Cancer 62:386–392

    PubMed  CAS  Google Scholar 

  • Yancopoulos GD, Klagsbrun M, Folkman J (1998) Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 93:661–664

    PubMed  CAS  Google Scholar 

  • Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ, Zabski S, Yancopoulos GD, Grumet M (2000a) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80:837–849

    CAS  Google Scholar 

  • Zagzag D, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M, Greco MA (1995) Tenascin expression in astro-cytomas correlates with angiogenesis. Cancer Res 55:907–914

    PubMed  CAS  Google Scholar 

  • Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wiegand SJ, Yancopoulos GD, Grumet M (1999) In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp. Neurol 159:391–400

    PubMed  CAS  Google Scholar 

  • Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE (1990) Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50:7393–7398

    PubMed  CAS  Google Scholar 

  • Zagzag D, Shiff B, Jallo GI, Greco MA, Blanco C, Cohen H, Hukin J, Allen JC, Friedlander DR (2002) Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 62:2660–2668

    PubMed  CAS  Google Scholar 

  • Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL (2000b) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2606–2618

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Freiburg Medical School, Breisacher Str. 64, Freiburg, 79106, Germany

    Marcia Machein & Lourdes Sánchez de Miguel

Authors
  1. Marcia Machein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lourdes Sánchez de Miguel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcia Machein .

Editor information

Editors and Affiliations

  1. Pathologisches Institut, UniversitäEtsklinikum Heidelberg, Abt. Neuropathologie, Germany

    Andreas von Deimling

  2. Deutsches Krebsforschungszentrum, Klinische Kooperationseinheit Neuropathologie, Im Neuenheimer Feld 220/221, Heidelberg, 69120, Germany

    Andreas von Deimling

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Machein, M., de Miguel, L.S. (2009). Angiogenesis in Gliomas. In: von Deimling, A. (eds) Gliomas. Recent Results in Cancer Research, vol 171. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-31206-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-31206-2_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-31205-5

  • Online ISBN: 978-3-540-31206-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation